Article
FDA Names Woodcock Permanent Director of CDER
Author(s):
On March 10, 2008, US Food and Drug Administration Commissioner Andrew von Eschenbach, MD, announced that Janet Woodcock, MD, has been appointed director of the agency's Center for Drug Evaluation and Research (CDER), following a national search.
On March 10, 2008, US Food and Drug Administration Commissioner Andrew von Eschenbach, MD, announced that Janet Woodcock, MD, has been appointed director of the agency’s Center for Drug Evaluation and Research (CDER), following a national search.
FDA announcement http://www.fda.gov/bbs/topics/NEWS/2008/NEW01804.html
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
